Mika Ishige

542 total citations
24 papers, 264 citations indexed

About

Mika Ishige is a scholar working on Clinical Biochemistry, Surgery and Molecular Biology. According to data from OpenAlex, Mika Ishige has authored 24 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Mika Ishige's work include Metabolism and Genetic Disorders (13 papers), Mitochondrial Function and Pathology (5 papers) and Respiratory viral infections research (3 papers). Mika Ishige is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Mitochondrial Function and Pathology (5 papers) and Respiratory viral infections research (3 papers). Mika Ishige collaborates with scholars based in Japan, United States and Germany. Mika Ishige's co-authors include Erika Ogawa, Tatsuo Fuchigami, Shori Takahashi, Yasushi Okazaki, Kei Murayama, Masakazu Kohda, Yoshihito Kishita, Tomoko Tsuruoka, Keiko Ichimoto and Akira Ohtake and has published in prestigious journals such as Molecular Genetics and Metabolism, Journal of Inherited Metabolic Disease and International Journal of Molecular Medicine.

In The Last Decade

Mika Ishige

24 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mika Ishige Japan 8 155 148 50 29 28 24 264
Tomoko Tsuruoka Japan 8 131 0.8× 190 1.3× 13 0.3× 14 0.5× 14 0.5× 18 241
Keiko Ichimoto Japan 8 133 0.9× 220 1.5× 12 0.2× 14 0.5× 32 1.1× 22 267
Catherine Lynn T. Silao Philippines 9 124 0.8× 79 0.5× 14 0.3× 61 2.1× 45 1.6× 33 287
Yaffa Elbaum Shiff Israel 7 46 0.3× 208 1.4× 34 0.7× 9 0.3× 20 0.7× 7 391
Yuqi Yang China 9 74 0.5× 138 0.9× 13 0.3× 22 0.8× 81 2.9× 32 367
Ronald J. Sokol United States 8 64 0.4× 77 0.5× 297 5.9× 10 0.3× 43 1.5× 8 443
Ayako Tabata Japan 9 415 2.7× 141 1.0× 197 3.9× 53 1.8× 30 1.1× 10 465
Yolanda Lillquist Canada 10 146 0.9× 121 0.8× 9 0.2× 52 1.8× 39 1.4× 17 250
Sylvia C. Estrada Philippines 7 113 0.7× 55 0.4× 59 1.2× 41 1.4× 130 4.6× 14 275
Sylwia Szymańska Poland 9 13 0.1× 49 0.3× 70 1.4× 24 0.8× 88 3.1× 40 262

Countries citing papers authored by Mika Ishige

Since Specialization
Citations

This map shows the geographic impact of Mika Ishige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Ishige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Ishige more than expected).

Fields of papers citing papers by Mika Ishige

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Ishige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Ishige. The network helps show where Mika Ishige may publish in the future.

Co-authorship network of co-authors of Mika Ishige

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Ishige. A scholar is included among the top collaborators of Mika Ishige based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Ishige. Mika Ishige is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mori, Masaaki, Shinichi Watabe, Mika Ishige, et al.. (2023). Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial. The Lancet Regional Health - Western Pacific. 39. 100847–100847. 4 indexed citations
3.
Ishige, Mika, et al.. (2023). Two-year interim safety and efficacy of pegvaliase in Japanese adults with phenylketonuria. Molecular Genetics and Metabolism. 140(3). 107697–107697. 2 indexed citations
4.
Fukuda, Tokiko, Tetsuya Ito, Takashi Hamazaki, et al.. (2023). Blood glucose trends in glycogen storage disease type Ia: A cross‐sectional study. Journal of Inherited Metabolic Disease. 46(4). 618–633. 5 indexed citations
5.
6.
Takano, Chika, Mika Ishige, Erika Ogawa, et al.. (2021). Nutrient management in the intrapartum period in maternal maple syrup urine disease. Molecular Genetics and Metabolism Reports. 26. 100711–100711. 1 indexed citations
7.
Nagano, Nobuhiko, Chika Takano, Erika Ogawa, et al.. (2021). Unique and abnormal subependymal pseudocysts in a newborn with mitochondrial disease. Science Progress. 104(2). 311982369–311982369. 4 indexed citations
8.
Kido, Jun, Shirou Matsumoto, Tetsuya Ito, et al.. (2021). Physical, cognitive, and social status of patients with urea cycle disorders in Japan. Molecular Genetics and Metabolism Reports. 27. 100724–100724. 12 indexed citations
9.
Takano, Chika, Erika Ogawa, Mika Ishige, et al.. (2020). Severe rotavirus gastroenteritis in children older than 5 years after vaccine introduction. Journal of Infection and Chemotherapy. 27(4). 598–603. 7 indexed citations
10.
Ishige, Mika, Tatsuo Fuchigami, Hironori Kobayashi, et al.. (2019). Primary carnitine deficiency with severe acute hepatitis following rotavirus gastroenteritis. Journal of Infection and Chemotherapy. 25(11). 913–916. 4 indexed citations
11.
Ogawa, Erika, et al.. (2018). Hypocarnitinemia Observed in an Infant Treated with Short-Term Administration of Antibiotic Containing Pivalic Acid. The Tohoku Journal of Experimental Medicine. 244(4). 279–282. 5 indexed citations
12.
Ogawa, Erika, Masaru Shimura, Takuya Fushimi, et al.. (2017). Clinical validity of biochemical and molecular analysis in diagnosing Leigh syndrome: a study of 106 Japanese patients. Journal of Inherited Metabolic Disease. 40(5). 685–693. 77 indexed citations
13.
Ishige, Mika, et al.. (2016). Severe Acute Subdural Hemorrhages in a Patient with Glutaric Acidemia Type 1 under Recommended Treatment. Pediatric Neurosurgery. 52(1). 46–50. 6 indexed citations
15.
Ogawa, Erika, et al.. (2016). Severe hypoglycemic encephalopathy due to hypoallergenic formula in an infant. Pediatrics International. 58(8). 778–781. 1 indexed citations
16.
17.
Tanaka, Akemi, Takashi Hamazaki, Torayuki Okuyama, et al.. (2015). Genotype of mucopolysaccharidosis type II severe form and the efficacy of enzyme replacement therapy or hematopoietic stem cell transplantation on cognitive function. Molecular Genetics and Metabolism. 114(2). S111–S112. 1 indexed citations
18.
Matsunami, Masatoshi, Akira Ishiguro, Akinari Fukuda, et al.. (2015). Successful living domino liver transplantation in a child with protein C deficiency. Pediatric Transplantation. 19(3). E70–4. 14 indexed citations
19.
Nagano, Nobuhiko, Tatsuhiko Urakami, Hirofumi Watanabe, et al.. (2012). Diabetes caused by Kir6.2 mutation: Successful treatment with oral glibenclamide switched from continuous subcutaneous insulin infusion in the early phase of the disease. Pediatrics International. 54(2). 277–279. 3 indexed citations
20.
Kasahara, Mureo, Seisuke Sakamoto, Hiroyuki Kanazawa, et al.. (2011). Living‐donor liver transplantation for propionic acidemia. Pediatric Transplantation. 16(3). 230–234. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026